Primary |
Cough |
20.0% |
Drug Abuse |
14.7% |
Nasopharyngitis |
12.0% |
Hypertension |
9.3% |
Bipolar Disorder |
8.0% |
Borderline Personality Disorder |
8.0% |
Pharyngolaryngeal Pain |
8.0% |
Bronchitis |
4.0% |
Analgesia |
1.3% |
Antitussive Therapy |
1.3% |
Asthma |
1.3% |
Blood Cholesterol Increased |
1.3% |
Convulsion |
1.3% |
Drug Dependence |
1.3% |
Gastrooesophageal Reflux Disease |
1.3% |
Malaise |
1.3% |
Pain |
1.3% |
Recreational Substance Use |
1.3% |
Respiratory Disorder |
1.3% |
Sedative Therapy |
1.3% |
|
Drug Abuse |
13.2% |
Epistaxis |
7.9% |
Overdose |
7.9% |
Sepsis |
7.9% |
Somnolence |
7.9% |
Cough |
5.3% |
Drug Dependence |
5.3% |
Therapeutic Response Unexpected |
5.3% |
Urticaria |
5.3% |
Vomiting |
5.3% |
Withdrawal Syndrome |
5.3% |
Circulatory Collapse |
2.6% |
Convulsion |
2.6% |
Diarrhoea |
2.6% |
Dizziness |
2.6% |
Drug Effect Incomplete |
2.6% |
Drug Ineffective |
2.6% |
Dyspnoea |
2.6% |
Dysuria |
2.6% |
Hallucination |
2.6% |
|
Secondary |
Cough |
25.7% |
Nasopharyngitis |
12.9% |
Seasonal Allergy |
11.4% |
Hypertension |
10.0% |
Product Used For Unknown Indication |
7.1% |
Bipolar Disorder |
4.3% |
Borderline Personality Disorder |
4.3% |
Pharyngolaryngeal Pain |
4.3% |
Sinus Congestion |
2.9% |
Sinus Headache |
2.9% |
Analgesia |
1.4% |
Antitussive Therapy |
1.4% |
Anxiety |
1.4% |
Blood Cholesterol Increased |
1.4% |
Bronchitis |
1.4% |
Gastrooesophageal Reflux Disease |
1.4% |
Malaise |
1.4% |
Myocardial Infarction |
1.4% |
Narcolepsy |
1.4% |
Pain |
1.4% |
|
Sepsis |
12.5% |
Off Label Use |
8.3% |
Urticaria |
8.3% |
Cardiac Arrest |
4.2% |
Cough |
4.2% |
Drug Ineffective |
4.2% |
Drug Interaction |
4.2% |
Dry Eye |
4.2% |
Dysphonia |
4.2% |
Dysuria |
4.2% |
Haemoptysis |
4.2% |
Loss Of Consciousness |
4.2% |
Medication Error |
4.2% |
Oral Infection |
4.2% |
Overdose |
4.2% |
Poor Quality Sleep |
4.2% |
Product Formulation Issue |
4.2% |
Pruritus |
4.2% |
Restlessness |
4.2% |
Withdrawal Syndrome |
4.2% |
|
Concomitant |
Drug Use For Unknown Indication |
16.7% |
Product Used For Unknown Indication |
14.0% |
Cough |
10.6% |
Pain |
7.4% |
Asthma |
7.1% |
Acute Myeloid Leukaemia |
3.9% |
Bronchitis |
3.9% |
Constipation |
3.9% |
Dyspnoea |
3.7% |
Nausea |
3.7% |
Blood Pressure |
2.9% |
Headache |
2.7% |
Hypothyroidism |
2.7% |
Depression |
2.5% |
Diabetes Mellitus |
2.5% |
Multiple Sclerosis |
2.5% |
Respiratory Tract Congestion |
2.5% |
Urinary Tract Infection |
2.5% |
Anxiety |
2.2% |
Fibromyalgia |
2.2% |
|
Pulmonary Embolism |
11.9% |
Pneumonia |
10.2% |
Sinus Disorder |
8.5% |
Swelling |
8.5% |
Rash |
6.8% |
Death |
5.1% |
Dyspnoea |
5.1% |
Cervical Dysplasia |
3.4% |
Drug Withdrawal Syndrome Neonatal |
3.4% |
Ill-defined Disorder |
3.4% |
Loss Of Consciousness |
3.4% |
Pneumonia Staphylococcal |
3.4% |
Pneumonitis |
3.4% |
Productive Cough |
3.4% |
Renal Failure |
3.4% |
Sepsis |
3.4% |
Type 2 Diabetes Mellitus |
3.4% |
Vomiting |
3.4% |
Vulval Cancer Stage 0 |
3.4% |
Weight Decreased |
3.4% |
|
Interacting |
Bipolar Disorder |
37.5% |
Borderline Personality Disorder |
37.5% |
Bronchitis |
12.5% |
Malaise |
12.5% |
|
Withdrawal Syndrome |
66.7% |
Dystonia |
33.3% |
|